| Similar Articles |
|---|
 |
Bio-IT World
June 15, 2003
Bob Violino |
Mid-Atlantic/Southeast Region Maryland: Making a Federal Case for Biotechnology... Puerto Rico: Isle of Incentives... Virginia: Planting Needed Seed Capital... North Carolina: Triangulating Biotech Resources... Florida: Shining Resources on Small Biotech Sector   |
Bio-IT World
June 15, 2003
Bob Violino |
Northeast Region Massachusetts: University and Research Hub... Connecticut: Investing in Bio Facilities... New York: Biotech Empire State... New Jersey: Still Big Pharma Country... Pennsylvania: Life Sciences, a Keystone Industry |
Bio-IT World
October 14, 2004
Robinson & Violino |
Strategic Insights: Global Positioning International Economic Development for biotech companies in search of a better location or international presence, countries in Asia and Europe are offering a host of incentives, including tax credits and reduced red tape. |
Bio-IT World
June 15, 2003
Barbara Depompa |
Southwest Region Texas: Bioscience with a Space Spin... New Mexico: Building a Bioinformatics Niche... Arizona: Focus on Cancer and Neurological Therapy... Southern California: Deep Biotech Roots Grow Many Branches... Northern California: 'Can You Afford To Be Elsewhere?'... |
Bio-IT World
May 19, 2004
Barbara Depompa |
From Corn Belt to Bio Belt The Danforth Center in St. Louis attempts to lay the foundation for the local chamber of commerce's efforts to promote the region as a world-class location for plant and life science research. |
Bio-IT World
June 2005
Dennis Yablonsky |
Pennsylvania: Home of the 'Biosciences Continuum' Through the involvement of industry, government, academia, financial institutions, medical providers, and a host of ancillary support organizations, Pennsylvania has become the only state that offers support along the entire biosciences continuum. |
Bio-IT World
June 15, 2003
Barbara Depompa |
Northwest Region Colorado: Biotech Summit in Denver... Utah: A Mecca for Genealogical Research... Washington State: Therapeutics and Diagnostics Niche... |
CFO
December 1, 2006
Kate O'Sullivan |
Biotech Dreaming Cities and states in the U.S. are vying to become biotechnology hot spots. Ultimately, some regions may not have enough of the key ingredients for biotech success. |
Pharmaceutical Executive
April 10, 2014
Christini & Kaitin |
Regional Trends in Bioinnovation Investment Can the Cambridge model be duplicated? |
Pharmaceutical Executive
September 1, 2008
Zhu Shen |
Unleash the Dragon Concerns over quality? It's not stopping Big Pharma outsourcing and venture capital. |
Bio-IT World
October 2006
Thomas G. Morr |
Eight Essential Elements for Commercial Success For life sciences companies both young and old, location is one of the critical success factors. With that in mind, here are eight essential considerations for life sciences executives when they are thinking of starting a business or opening a new location. |
Pharmaceutical Executive
January 1, 2011 |
The San Diego Story San DIego works as a locus for risky investments in the big ideas that lead to biotech breakthroughs |
Pharmaceutical Executive
December 1, 2010
Zhu Shen |
China 2020: Walled In No More Pharma sets the pace for China's ambitious new innovation agenda |
Commercial Investment Real Estate
May/Jun 2005
Bell & Drummond |
Biotech Boom Biotech tenants have specific needs for lab/office space, but they do not need a physical link to a city's business center. In addition to biotech, the nanotech and biopharmaceutical industries are also growing quickly. |
Bio-IT World
April 2006
Laura Huckabee-Jennings |
Southern Emergence Why Huntsville, Alabama, will be the next biotech hotbed. |
Inc.
November 1, 2002
Emily Barker |
Universities: Your New Best Friend For resource-hungry entrepreneurs, the explosion of university-based business-development programs comes as sweet relief in tight economic times. From Ann Arbor to Chapel Hill, find out what's out there for you -- and why colleges are in such a giving mood. |
Bio-IT World
October 2005
Bjorn Bergstrand |
Swedish Biotech: A Golden Opportunity With the largest share of biotech companies per capita and prestigious research institutes, Sweden offers business opportunities for industrial and financial investors alike. |
Pharmaceutical Executive
October 1, 2005
Mark J. Ahn |
It's All Academic: Biotechs Looking to Universities Pharmaceuticals and academic institutions are forming alliances at an increasing rate to exploit the promise of emerging biological insights. |
IndustryWeek
November 1, 2002
Tonya Vinas |
Questioning Biotech's Benefits While most communities are investing to attract or grow biotechnology companies, a recent report concludes that only a handful of cities will benefit in the long run. |
The Motley Fool
January 31, 2011
Brian Orelli |
Pharma Goes Back to School But will it produce more drugs? The pharmaceutical industry is headed back to school, with a number of large drugmakers announcing partnerships with universities. |
Chemistry World
May 19, 2008
Hepeng Jia |
China's one stop research shop John Oyler has founded a string of startups in the US, but in 2005 he chose China as his base to launch BioDuro, a life sciences Contract Research Organisation. |
| Knowledge@Wharton |
From Skin Creams to Life Insurance to Medical Care, Biosciences Are the New Frontier of Business Opportunity Research in the biological sciences holds the potential for breakthroughs that could transform the world. But scientific advances also can be baffling and more than a little intimidating, especially for business people... |
Inc.
October 2006 |
Best On: Tech Transfer The best candidates for governor based on tech transfer. |
Pharmaceutical Executive
July 10, 2014
William Looney |
Pharm Exec's 2014 Dealmakers Outlook As the pacing picks up around dealmaking as the alternative to organic growth, Pharm Exec brings together experts from big Pharma and biotech to dissect the road ahead. |
Pharmaceutical Executive
June 1, 2012 |
2012 Dealmakers Outlook With Yankee Stadium as the backdrop, Pharm Exec convened on its annual panel of heavy hitters in business development to crack the bat on best practices in licensing and for the year ahead. |
National Real Estate Investor
August 1, 2006
Parke M. Chapman |
Development Pinch Hitters Speculative development is a new twist on a traditional economic development model. |
IndustryWeek
December 1, 2006
John S. McClenahen |
Rust Belt Rebound? In America's heartland particularly, manufacturing seems to be making a comeback. But only here and there. And how long will that last? |
BusinessWeek
September 4, 2008
Pete Engardio |
Chinese Scientists Build Big Pharma Back Home In a reverse migration, U.S.-trained scientists are setting up biotech startups, contract-research companies, and university labs on the mainland. |
Pharmaceutical Executive
December 1, 2011
George Baeder |
China's Future in Bioscience Will big investments in infrastructure carry the day in positioning China as a global drug innovation powerhouse? |
| Knowledge@Wharton |
Encouraging the Development of Drugs for Poor, not Just Rich, Nations The current system rewards research into diseases that afflict rich countries, but creating new medicines for the rest of the world and finding ways to pay for them will demand new partnerships, according to panelists at the recent conference "Pharmaceutical Innovation in a Global Economy." |
Job Journal
August 8, 2004
Rich Heintz |
Biotech's Winning Formula for Steady Job Growth Deep pockets are creating expanding opportunities and biotechnology is helping to put America back to work. |
Chemistry World
April 21, 2009
Matt Wilkinson |
Survival of the fittest While the pharmaceutical and biopharmaceutical sectors in general are outperforming broader stock market trends, many early stage companies are desperately trying to conserve cash and raise money to keep going. |
HBS Working Knowledge
December 8, 2003
Sean Silverthorne |
Why Europe Lags in Pharmaceuticals and Biotech Governmental, cultural and academic differences are hurting Europe's chances of gaining on the U.S. Can anything be done? |
IndustryWeek
October 19, 2011 |
How to Move Into Different Sector With Success Stung by the automotive recession, manufacturers seek new opportunities in the burgeoning health care products market. |
Job Journal
July 16, 2006
Julia Hollister |
Biotech Boom The biotech field offers promising jobs in a profession that's expanding faster than you can spell biotherapeutics. |
Entrepreneur
September 2005
Stephen Barlas |
Border Patrol Congress goes to bat for in-state expansion tax incentives. |
D-Lib
December 2008
Peter A. Zuber |
A Study of Institutional Repository Holdings by Academic Discipline In some academic disciplines, participation in institutional repositories is low and it may be difficult to persuade faculty to contribute research. |
Chemistry World
May 19, 2010
Rebecca Trager |
NIH spends $1 billion on research construction projects The US National Institutes of Health has awarded $1 billion ( 700 million) to universities and medical centers across the country for the construction or upgrading of scientific research laboratories. |
Inc.
May 1, 2002
Kenneth Klee |
The Industry You Can't Afford to Miss After more than two decades of hype, hope, disappointment, and progress, the hundreds of mostly small, money-burning companies that make up the biotech industry are experiencing a decisive shift in their relationship with the giant, rich pharmaceutical companies... |
Sports Central
February 4, 2013
Andrew Jones |
NCAA Contenders and Pretenders As of the week 13 rankings released on January 28, 10 teams have been in the AP top five at one point or another this season: Michigan, Kansas, Indiana, Florida, Duke, Syracuse, Louisville, Arizona, Ohio State, and Kentucky. |
Knowledge@Wharton
October 8, 2003 |
Biosciences: High Risk, High Reward, and the Potential for "Real Chaos" While bioscience researchers struggle to understand the workings of the human body, biotech managers and investors are searching for ways to better understand this complex and quickly evolving industry, according to Wharton faculty and lecturers. |
Chemistry World
February 2008
Nuala Moran |
The Chemistry of Private Equity Private equity has transformed the chemicals industry, but can it play the same role in high-risk R&D driven companies? |
Pharmaceutical Executive
June 1, 2011 |
Emerging Pharma Leaders 2011 Meet 2011's Emerging Pharma Leaders. Can these 30 trendsetters build competitive scale from scarcity? |
Pharmaceutical Executive
December 1, 2008
Walter Armstrong |
The New Deals Everything you wanted to know about the year's most important deals, and what to watch for in the future. |
Pharmaceutical Executive
May 1, 2005 |
Thought Leaders: Playing Field in Biotech/Pharma Partnerships Levels As infrastructure and business savvy within biotechs become increasingly sophisticated, the sector's relationship with pharma is taking on a new shape. An interview with industry veteran Lisa Drakeman on how to integrate cultures and processes and where pharma is falling short. |
IndustryWeek
April 1, 2007
John Teresko |
DuPont Does The DNA Dance Biotechnology is reshaping the world through our medicine, food, agriculture, materials and fuel. DuPont sees biotech as the ideal tool to improve productivity, quality and sustainability. |
Bio-IT World
July 14, 2004 |
Not Just a Day at the Beach Joseph Panetta recalls leaving the comfort of a pharma job in Philadelphia for a position in biotech in San Diego, whose fledgling biotech community survived stormy nascent years to mushroom into a biotech hotbed. |
IndustryWeek
April 15, 2009
Jonathan Katz |
Midwest Still Tops in Trade Ball State report card gives the Great Lakes region an 'A' for its global position. |
IndustryWeek
February 15, 2012
Adrienne Selko |
Ohio's Secret -- Business-Friendly Tax Code Has tax reform helped attract manufacturers to state? |
Bio-IT World
September 11, 2003 |
Show Me the Evidence ... Some emerging bio-IT services companies are beginning to attract venture capital. |
